These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23441974)

  • 21. Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain.
    Kavanagh S; Kwong WJ; Hammond GC; Nelson W; Upmalis D; Yang M
    Pain Med; 2012 Sep; 13(9):1110-20. PubMed ID: 22845494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical resource use and costs among pain patients with potential opioid-tolerability issues.
    Kirson NY; Shei A; Birnbaum HG; Ben-Joseph R; Michna E
    J Opioid Manag; 2014; 10(5):305-10. PubMed ID: 25350472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral.
    Offord S; Wong B; Mirski D; Baker RA; Lin J
    J Med Econ; 2013; 16(2):231-9. PubMed ID: 23163287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
    Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
    J Med Econ; 2012; 15(1):19-31. PubMed ID: 21970699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.
    Burton TM; Lacey M; Liu F; Yu Y; Monsalvo ML; Lang K; Sander S
    J Med Econ; 2012; 15(6):1217-25. PubMed ID: 22857539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipation.
    Iyer S; Davis KL; Candrilli S
    Manag Care; 2010 Mar; 19(3):44-51. PubMed ID: 20361548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
    Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
    Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
    Jackson J; Fernandes AW; Nelson W
    Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population.
    Furst DE; Clarke A; Fernandes AW; Bancroft T; Gajria K; Greth W; Iorga SR
    J Med Econ; 2013; 16(4):500-9. PubMed ID: 23363329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health care utilization, costs, and readmission rates associated with hyponatremia.
    Deitelzweig S; Amin A; Christian R; Friend K; Lin J; Lowe TJ
    Hosp Pract (1995); 2013 Feb; 41(1):89-95. PubMed ID: 23466971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost and utilization outcomes of opioid-dependence treatments.
    Baser O; Chalk M; Fiellin DA; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S235-48. PubMed ID: 21761950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
    Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
    J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid analgesic-treated chronic pain patients at risk for problematic use.
    Tkacz J; Pesa J; Vo L; Kardel PG; Un H; Volpicelli JR; Ruetsch C
    Am J Manag Care; 2013 Nov; 19(11):871-80. PubMed ID: 24511985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare costs and nonadherence among chronic opioid users.
    Leider HL; Dhaliwal J; Davis EJ; Kulakodlu M; Buikema AR
    Am J Manag Care; 2011 Jan; 17(1):32-40. PubMed ID: 21348566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study.
    Cepeda MS; Fife D; Vo L; Mastrogiovanni G; Yuan Y
    J Pain; 2013 Feb; 14(2):158-64. PubMed ID: 23253635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis.
    Gore M; Tai KS; Sadosky A; Leslie D; Stacey BR
    J Med Econ; 2011; 14(4):497-507. PubMed ID: 21682606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.